Article 16 May 2024 Summary And Key Considerations Of Recent HHS-OIG Advisory Opinion On Pharmaceutical Patient Assistance Program For Rare Disorders United States Healthcare
Article 10 May 2024 FDA Finalizes Rule To Assert Authority Over Laboratory Developed Tests United States Healthcare
Article 14 Dec 2023 Biden Administration Releases Draft Framework For Exercising Bayh-Dole March-in Rights Taking Into Account Drug Prices United States Healthcare
Article 21 Feb 2023 OIG Technical Assistance On Part B Inflation Rebates Implementation Barriers And CMS' Proposed Solutions In Recent Part B Inflation Rebate Initial Guidance United States Healthcare
Article 27 Nov 2020 Summary Of Trump Administration Drug Pricing And AKS Rulemakings And Implications For Life Sciences Companies And Health Care Providers United States Healthcare
Article 11 Aug 2020 President Signs Executive Order To Ensure Essential Medical Products Are Made In The USA United States Government
Article 19 May 2020 New Federal COVID-19 Appropriations For Healthcare Providers: The Paycheck Protection Program And Health Care Enhancement Act United States Coronavirus
Article 21 Apr 2020 What Clinical Diagnostic Laboratories And Manufacturers Need To Know About The CARES Act United States Coronavirus
Article 28 May 2019 CMS Final Rule Requires Prescription Drug Pricing Transparency In DTC Advertising United States Healthcare